SCHEMBL6462115

SCHEMBL6462115

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@H]2CC[C@]2(C)C(CO)CC[C@@H]12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.72
LMNA P02545 7/20 0.72
MAPT P10636 6/20 0.72
SHBG P04278 5/20 0.72
TSHR P16473 5/20 0.72
HSD17B10 Q99714 4/20 0.72
SERPINA6 P08185 4/20 0.72
MAPK1 P28482 4/20 0.72
NR3C1 P04150 4/20 0.72
PGR P06401 4/20 0.72
AR P10275 4/20 0.72
GPBAR1 Q8TDU6 3/20 0.72
SIGMAR1 Q99720 3/20 0.72
CYP19A1 P11511 2/20 0.72
SNCA P37840 2/20 0.72
CACNA1C Q13936 2/20 0.72
CYP51A1 Q16850 2/20 0.72
OR51E2 Q9H255 1/20 0.72
SMN1; SMN2 Q16637 5/20 0.71
ALDH1A1 P00352 4/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6462109 1.00 CYP3A4 (0.72) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL13310373 1.00 CYP3A4 (0.72) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL9351748 1.00 CYP3A4 (0.72) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL19635112 0.91 CYP3A4 (0.69) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL22475606 0.91 CYP3A4 (0.69) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL20402646 0.91 CYP3A4 (0.69) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL21367235 0.91 CYP3A4 (0.69) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL10796253 0.91 CYP3A4 (0.69) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL15672642 0.89 CYP3A4 (0.70) CYP3A4LMNAMAPTSHBGTSHR
SCHEMBL14150045 0.89 CYP3A4 (0.70) CYP3A4LMNAMAPTSHBGTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6881728-B1 14-β, 17-α-hydroxymethylandrostane derivatives as androgens AKZO NOBEL N.V. (NL) 2005-04-19 US disclosed
EP-1163259-B1 14.BETA.,17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS AKZO NOBEL NV (NL) 2002-11-20 EP disclosed
EP-0375351-B1 Phosphonic acid substituted steroids as steroid 5alpha-reductase inhibitors SMITHKLINE BEECHAM CORP (US) 1994-08-31 EP disclosed
EP-0289327-B1 STEROID 5-ALPHA-REDUCTASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1991-12-18 EP disclosed
US-5017568-A Enzyme inhibitors, carboxylation SMITHKLINE BEECHAM CORPORATION (US) 1991-05-21 US disclosed
US-4946834-A ACRYLATE ANALOGUES OF STEROIDAL SYNTHETIC COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1990-08-07 US disclosed
EP-0375351-A1 Phosphonic acid substituted steroids as steroid 5alpha-reductase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1990-06-27 EP disclosed
US-4910226-A Estrane compound SMITHKLINE BECKMAN CORPORATION (US) 1990-03-20 US disclosed
EP-0289327-A2 Steroid 5-alpha-reductase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-11-02 EP disclosed
US-4317817-A SKIN DISORDERS; ACEME; ENZYME INHIBITORS RICHARDSON-MERRELL INC. (US) 1982-03-02 US disclosed